Literature DB >> 22617280

Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients.

Joo Hyun Kim1, Seunghyong Ryu, Hee Jung Nam, Meerae Lim, Ji Hyun Baek, Yeon Ho Joo, Jun Soo Kwon, Tae Hyon Ha, Kyung Sue Hong.   

Abstract

OBJECTIVE: The use of clozapine or other second generation antipsychotics (SGAs) has been reported to produce obsessive compulsive (OC) symptoms as adverse mental affects. However, it is not yet clear if SGA-induced OC symptoms have the same phenomenological characteristics as those displayed in obsessive compulsive disorder (OCD). This study investigated the nature of symptoms and dimensions of SGA-induced OC symptoms in schizophrenia patients, which were then compared with those reported in pure OCD.
METHODS: The study subjects were fifty-one schizophrenia patients with SGA-induced OC symptoms. Symptom evaluation was performed using the Korean version of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Exploratory factor analysis of symptom categories of Y-BOCS symptom checklist (Y-BOCS-SC) was conducted.
RESULTS: Frequencies of individual symptom categories were comparable to those reported in Korean OCD patients. Five factors (forbidden thoughts, hoarding, cleaning, symmetry, and counting) were generated from 13 main symptom categories, which accounted for 70.7% of the total variance. This factor structure is also remarkably similar to those reported in pure OCD patients. The factor score of 'cleaning' was significantly correlated with the overall severity of OC symptoms (P<0.01).
CONCLUSION: A high level of similarity between the nature of symptoms and dimensions identified in patients with SGA-induced OC symptoms and those revealed in OCD patients suggests a common biological mechanism underlying these two clinical conditions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617280     DOI: 10.1016/j.pnpbp.2012.05.011

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  4 in total

Review 1.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

2.  Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.

Authors:  Mats B Humble; Kerstin Uvnäs-Moberg; Ingemar Engström; Susanne Bejerot
Journal:  BMC Psychiatry       Date:  2013-12-23       Impact factor: 3.630

3.  Clinical correlates of obsessive-compulsive disorder comorbidity in patients with schizophrenia.

Authors:  Ahmet Kokurcan; Şerif Bora Nazlı
Journal:  Indian J Psychiatry       Date:  2020-01-03       Impact factor: 1.759

4.  Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia.

Authors:  Emilio Fernandez-Egea; Yulia Worbe; Miguel Bernardo; Trevor W Robbins
Journal:  Psychol Med       Date:  2018-02-19       Impact factor: 7.723

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.